Abstract:OBJECTIVE To investigate the feasibility of vascular graft material polytetrafluoroethylene (PTFE) as gene carrier of vascular endothelial growth factor (VEGF). METHODS The PTFE strips were soaked in pCDI-hVEGF(121) solution,marked with EB solution, and then observed under ultraviolet light. The PTFE strips carrying pCDI-hVEGF(121) were soaked in normal saline and the value of optical density at 260 nm on different time was measured, then the controlled release curve was made. The PTFE strips carrying pCDI-hVEGF(121) were implanted into the left thigh muscles of rabbits and the PTFE strips without VEGF gene were implanted into the right. The expression of VEGF(121) mRNA versus beta-actin mRNA in muscles around vascular graft materials was evaluated by reverse transcriptase polymerase chain reaction(RT-PCR). The expression of VEGF(121) protein in muscle was determined by Western blot method. RESULT The fluorescence on PTFE strips carrying pCDI-hVEGF(121) was observed under ultraviolet light. The controlled release curve demonstrated that the gene release was fast during 0.5 -4 h, then slowed down afterwards,and lasted for 72 h. RT-PCR and Western blot showed VEGF(121)/beta-actin mRNA ratios were 1.053+/-0.356,1. 718+/-0.404, 2.021+/-0.303, 1.872+/-0.231, 0.986+/-0.254, 0.340+/-0.116 and VEGF(121)protein expression levels were 0.328+/-0.088, 1.019+/-0.105, 2.249 +/-0.203, 2.036+/-0.079, 1.670+/-0.132, 0.636+/-0.107 at 1, 7, 14, 28, 42, and 56 days after implantation, respectively. CONCLUSION The PTFE graft can be used as carrier of VEGF gene and VEGF gene can be transferred to skeletal muscle by this method.

[Construction of Co-Expression Plasmid Containing Tpa and VEGF165 Genes and Its Expression in VSMCs].

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

[Effects of Co-Expression Plasmid of Human Tpa and VEGF165 on the Proliferation of Vascular Cells and Fibrinolysis Activity].

Construction of Eukaryotic Expression Plasmid Containing Tpa Genes and Its Expression in Transfected VSMCs

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

A study on biological activity of co-expression plasmid of human tissue plasminogen activator and vascular endothelial growth factor 165

Construction and Biological Activities of Human Tpa Eukaryotic Expression Plasmid.

Construction of Eukaryotic Expression Fusion Plasmid of HPV6b E7 Gene and CRT Gene

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of pcDNA3-Endo eukaryon expression plasmid and angiogenesis inhibition in vitro

Construction of a Eukaryotic Expression Vector Pegfp-C1-bmp-2

Construction of the Prokaryotic Expression Vector of Human Tissue-Type Plasminogen Activator and Its Preliminary Expression in Escherichia coli

[Expression of VEGF165 and VEGF121 Genes in MC3T3-E1 Cell Line and Biological Function of Their Products].

Cloning of human vascular endothelial growth factor cDNA and its expression in COS-7 cells

Production of Human Vascular Endothelial Growth Factor in Silkworm by Using a Recombinant Baculovirus

Promotive effect of polytetrafluoroethylene vascular grafts carrying VEGF gene on the growth of endothelial cells

Construction of Recombinant Plasmid Containing Mouse Vasoactive Intestinal Peptide Gene and Its Expression in COS-7 Cells

Effect of human VEGF165 in vitro on proliferation of vascular endothelial cells

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

[Application of Polytetrafluoroethylene As VEGF Gene Carrier].

Construction and Expression in HUVEC of Eukaryotic Expressed Plasmid Vector Pcmv-(Kozak) TFPI